BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2994910)

  • 1. Changes in serum osteocalcin associated with parathyroid hormone infusion in X-linked hypophosphatemic rickets.
    Cole DE; Gundberg CM
    Clin Chim Acta; 1985 Sep; 151(1):1-7. PubMed ID: 2994910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum parathyroid hormone concentrations in hypophosphataemic vitamin D resistant rickets.
    Fanconi A; Fischer JA; Prader A
    Helv Paediatr Acta; 1974 Aug; 29(3):187-94. PubMed ID: 4369169
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
    Bai X; Miao D; Li J; Goltzman D; Karaplis AC
    Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum osteocalcin as an index of altered bone metabolism.
    Kruse K; Kracht U
    Eur J Pediatr; 1986 Apr; 145(1-2):27-33. PubMed ID: 3015628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG; Quigley R; Baum M
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
    J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone secretion in familial vitamin-D-resistant rickets.
    Reitz RE; Weinstein RL
    N Engl J Med; 1973 Nov; 289(18):941-5. PubMed ID: 4355232
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
    Lewy JE; Cabana EC; Repetto HA; Canterbury JM; Reiss E
    J Pediatr; 1972 Aug; 81(2):294-300. PubMed ID: 4339535
    [No Abstract]   [Full Text] [Related]  

  • 11. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
    McElduff A; Posen S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
    Short E; Morris RC; Sebastian A; Spencer M
    J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteocalcin has limited usefulness as a diagnostic marker for rickets.
    Daniels ED; Pettifor JM; Moodley GP
    Eur J Pediatr; 2000 Oct; 159(10):730-3. PubMed ID: 11039126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor (FGF)-23 and hypophosphatemic rickets/osteomalacia.
    Fukumoto S; Yamashita T
    Endocr J; 2001 Dec; 48(6):603-10. PubMed ID: 11873859
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum osteocalcin concentrations in patients with rheumatoid arthritis.
    Pietschmann P; Machold KP; Wolosczuk W; Smolen JS
    Ann Rheum Dis; 1989 Aug; 48(8):654-7. PubMed ID: 2789500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.
    Chen C; Carpenter T; Steg N; Baron R; Anast C
    Pediatrics; 1989 Aug; 84(2):276-80. PubMed ID: 2787497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats.
    Lian JB; Carnes DL; Glimcher MJ
    Endocrinology; 1987 May; 120(5):2123-30. PubMed ID: 3494594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.